Addex Therapeutics (ADXN) Institutional Ownership $8.09 +0.30 (+3.85%) Closing price 05/1/2025 03:37 PM EasternExtended Trading$8.57 +0.48 (+5.95%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Addex Therapeutics (NASDAQ:ADXN)CurrentInstitutional OwnershipPercentage16.14%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$141.41KNumber ofInstitutional Sellers(last 12 months)0 Get ADXN Insider Trade Alerts Want to know when executives and insiders are buying or selling Addex Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ADXN Institutional Buying and Selling by Quarter Addex Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/7/2025 GAMMA Investing LLC8,757$64K0.0%+766.2%0.826% 2/17/2025Citadel Advisors LLC12,079$85K0.0%N/A1.140% 2/13/2024Armistice Capital LLC43,000$260K0.0%-92.0%4.343% 11/15/2023Armistice Capital LLC537,000$206K0.0%+103.4%65.328% 5/1/2023Virtu Financial LLC42,912$41K0.0%+203.8%0.334% 2/14/2023Susquehanna International Group LLP72,142$45K0.0%N/A0.561% 2/10/2023NEA Management Company LLC1,080,000$113K0.0%-80.9%8.398% 11/14/2022Armistice Capital LLC320,000$256K0.0%+26.5%2.941% 11/14/2022NEA Management Company LLC5,648,690$830K0.0%+500.0%51.923% 8/5/2022OLD Mission Capital LLC31,134$36K0.0%N/A0.286% 8/12/2021New Leaf Venture Partners L.L.C.50,000$478K0.1%N/A0.609% 8/2/2021NEA Management Company LLC180,000$17.21M0.2%N/A2.192% 5/21/2021Citadel Advisors LLC11,604$121K0.0%N/A0.141% 5/18/2021Citadel Advisors LLC11,604$121K0.0%N/A0.212% 5/12/2021UBS Group AG2,520$26K0.0%+2,420.0%0.046% (Data available from 1/1/2016 forward) ADXN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ADXN shares? During the previous two years, the following institutional investors and hedge funds held shares of Addex Therapeutics shares: Armistice Capital LLC ($260K), and Citadel Advisors LLC ($85K), GAMMA Investing LLC ($64K).Learn more on ADXN's institutional investors. What percentage of Addex Therapeutics stock is owned by institutional investors? 16.14% of Addex Therapeutics stock is owned by institutional investors. Learn more on ADXN's institutional investor holdings. Which institutional investors have been buying Addex Therapeutics stock? The following institutional investors have purchased Addex Therapeutics stock in the last 24 months: Armistice Capital LLC ($273K), Citadel Advisors LLC ($12.08K), and GAMMA Investing LLC ($7.75K). How much institutional buying is happening at Addex Therapeutics? Institutional investors have bought a total of 292,825 shares in the last 24 months. This purchase volume represents approximately $2.24M in transactions. Which Addex Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Addex Therapeutics stock in the last 24 months: Armistice Capital LLC ($494K). How much institutional selling is happening at Addex Therapeutics? Institutional investors have sold a total of 494,000 shares in the last 24 months. This volume of shares sold represents approximately $2.99M in transactions. Related Companies Aligos Therapeutics Major Shareholders Generation Bio Major Shareholders VYNE Therapeutics Major Shareholders Daré Bioscience Major Shareholders Clene Major Shareholders Tempest Therapeutics Major Shareholders Q32 Bio Major Shareholders Lexaria Bioscience Major Shareholders Cara Therapeutics Major Shareholders Cyclo Therapeutics Major Shareholders This page (NASDAQ:ADXN) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADXN Stock Free ADXN Stock Alerts